| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 14,666.50 | 11,258.83 | 11,771.67 | 11,055.93 |
| Sale of Products | 13,953.11 | 10,779.78 | 10,691.46 | 10,873.67 |
| Sale of Services | 363.32 | 263.29 | 567.02 | 27.35 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 9,055.16 | 8,698.41 | 7,680.43 | 8,095.48 |
| Property, Plant and Equipments | 4,584.17 | 4,289.60 | 4,174.07 | 4,382.90 |
| Right-of-Use Assets | 314.38 | 355.42 | 375.76 | 0.00 |
| Intangible Assets | 3,979.75 | 3,710.22 | 2,831.79 | 3,497.86 |
| Market Cap (Rs in Crs) | 87,719.84 | |
|---|---|---|
| P/E | 28.04 | |
| Book Value (Rs) | 481.38 | |
| Div (%) | 400 | |
| Market Lot | 1 | |
| EPS (TTM) | 68.52 | |
|---|---|---|
| Price/Book | 3.99 | |
| Div Yield.(%) | 0.42 | |
| Face value (RS) | 2 | |
| Deliverables (%) | 40.58 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 3,96,394.13 | 1,652.10 | 1,688.75 | -2.17 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,42,920.32 | 5,383.70 | 5,389.50 | -0.11 | 6,448.75 - 3,640.10 |
| Cipla Ltd | 1,14,382.81 | 1,416.30 | 1,433.45 | -1.20 | 1,702.00 - 1,310.05 |
| Torrent Pharmac... | 1,05,811.91 | 3,126.55 | 3,244.50 | -3.64 | 3,589.95 - 2,508.65 |
| Mankind Pharma ... | 95,480.99 | 2,314.25 | 2,343.55 | -1.25 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 10,21,46,179 | 22.39 |
| Total Institutions | 11,28,53,742 | 24.74 |
| Total Govt Holding | 35,632 | 0.01 |
| Total Non Promoter Corporate Holding | 13,81,607 | 0.30 |
| Total Promoters | 21,42,07,514 | 46.95 |
| Total Public & others | 25609868 | 5.62 |
| Total | 45,62,34,542 | 100 |
